In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stryker And St. Jude Acquisitions Signal Year-end Uptick In Device M&A

Executive Summary

The M&A market for medtech companies had already slowly started to climb off the mat after last year's collapse when Stryker and St. Jude Medical closed on two $1 billion-plus acquisitions. Still, Stryker's bid to acquire the neurovascular business of Boston Scientific and St. Jude's offer for structural heart disease company AGA Medical demonstrate how deep strategic acquirers are willing to dig to establish themselves in new markets.The combined price tag of $2.7 billion guaranteed that 2010 will be a better year for medical device mergers and acquisitions than 2009, at least as measured by disclosed prices paid.
Advertisement

Related Content

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2010
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2010
Device M&A Poised For A Strong Year
Device M&A Poised For A Strong Year
Top Device Stories Of 2010: Waiting For The Other Shoes To Fall
Top Device Stories Of 2010: Waiting For The Other Shoes To Fall
Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions
Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions
Edwards: Transcatheter Valve Leader Proves You Can Go Home Again

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel